Analysis of hormonal status and the course of endometriosis in patients with type 1 diabetes mellitus DOI

Elena V. Misharina,

Alena V. Tiselko, Maria I. Yarmolinskaya

и другие.

Journal of obstetrics and women s diseases, Год журнала: 2025, Номер 73(6), С. 101 - 115

Опубликована: Янв. 30, 2025

Background: Type 1 diabetes mellitus and endometriosis significantly reduce the quality of patient’s life hinder implementation reproductive plans. Studying features clinical course in patients with type will help development new effective safe therapeutic strategies diagnostic methods. Aim: The aim this study was to analyze diseases, hormonal status blood vitamin D (25-hydroxycalciferol) levels combined endometriosis. Materials methods: This prospective included 339 women, whom 79 were (mean age 31.7 ± 5.0 years), 51 31.4 3.7 209 30.2 4.9 years). control group consisted 31 healthy women age. immunochemiluminescent method used determine serum anti-Müllerian hormone, follicle-stimulating luteinizing prolactin, estradiol (days 2–5 menstrual cycle), progesterone 20–23 cycle) during three consecutive cycles, level glycated hemoglobin also studied mellitus. diagnosis all confirmed based on laparoscopic surgery verification by histological examination. Results: When assessing gonadotropins, hormone endometriosis, a decrease noted comparison other groups. gonadotropins prolactin groups comparable. In groups, days cycle lower than group. concentration patients’ peripheral compared group, minimum value 16.3 4.1 ng/ml found those disease no differences between onset its duration, total daily insulin dose, dose per kilogram weight. higher distributing grades prevalence, it that III IV more common without incidence deep infiltrating only, as number reoperations. Conclusions: asymptomatic preclinical period may lead untimely erroneous delayed treatment disease. puberty suffering from risk vascular complications increases ovarian reserve decreases, which requires goals early possible. choosing therapy for mellitus, presence should be taken into account.

Язык: Английский

Investigating the Interplay: Periodontal Disease and Type 1 Diabetes Mellitus - A Comprehensive Review of Clinical Studies DOI Open Access

Stefania Vlachou,

Alexandre Loumé,

Catherine Giannopoulou

и другие.

Опубликована: Апрель 15, 2024

Diabetes mellitus (DM) poses a significant challenge to global health, with its prevalence projected rise dramatically by 2045. This narrative review explores the bidirectional relationship between periodontitis (PD) and type 1 diabetes (T1DM), focusing on cellular molecular mechanisms derived interplay oral microbiota host immune response. A comprehensive search of literature published 2008 2023 was conducted elucidate association these two diseases. Preclinical clinical evidence suggests relationship, individuals T1DM exhibiting heightened susceptibility periodontitis, vice versa. The includes recent findings from human studies, revealing variations in composition patients, including increases certain pathogenic species such as Porphyromonas gingivalis, Prevotella intermedia, Aggregatibacter actinomycetemcomitans, along shifts microbial diversity abundance. Molecular underlying this involve oxidative stress dysregulated responses, mediated inflammatory cytokines IL-6, IL-8, MMPs. Furthermore, disruptions bone turnover markers, RANKL OPG, contribute periodontal complications patients. While preventive measures manage patients may improve overall health outcomes, further research is needed understand intricate interactions microbiota, response, disease, systemic population.

Язык: Английский

Процитировано

4

Glucose Targets Using Continuous Glucose Monitoring Metrics in Older Adults With Diabetes: Are We There Yet? DOI
Elena Toschi, David N. O’Neal, Medha Munshi

и другие.

Journal of Diabetes Science and Technology, Год журнала: 2024, Номер 18(4), С. 808 - 818

Опубликована: Май 7, 2024

The older population is increasing worldwide and up to 30% of adults have diabetes. Older with diabetes are at risk glucose-related acute chronic complications. Recently, mostly in type 1 (T1D), continuous glucose monitoring (CGM) devices proven beneficial improving time range (TIR glucose, 70-180 mg/dL or 3.9-10 mmol/L), glycated hemoglobin (HbA1c), lowering hypoglycemia (time below [TBR] <70 <3.9 mmol/L). international consensus group formulated CGM glycemic targets relating based on very limited data. Their recommendations, expert opinion, were aimed mitigating all adults. However, a heterogeneous group, ranging from healthy complex frail individuals chronological, biological, functional aging. Recent clinical trial real-world data, T1D, demonstrated that often achieve targets, including TIR recommended for non-vulnerable groups, but less meet the TBR <1%. Existing data also support avoidance may be more strongly related minimization variability (coefficient variation [CV]) rather than lower TIR. Very available goals adjusted complexity their health status. Herein, we review bidirectional associations between status diabetes; use technologies, impact control; discuss current guidelines; propose new set insulin-treated individualized living

Язык: Английский

Процитировано

4

Age-standardized incidence, prevalence, mortality rates and future projections of autoimmune diseases in China: a systematic analysis based on GBD 2021 DOI
Yanhua Xiao, Xuezhi Hong,

Ranjana Neelagar

и другие.

Immunologic Research, Год журнала: 2025, Номер 73(1)

Опубликована: Янв. 6, 2025

Язык: Английский

Процитировано

0

Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2024 DOI Creative Commons
Toralf Schwarz,

Christoph Niederau,

Stefan Pleus

и другие.

Deleted Journal, Год журнала: 2025, Номер 21(1), С. 45 - 56

Опубликована: Янв. 1, 2025

Процитировано

0

Analysis of hormonal status and the course of endometriosis in patients with type 1 diabetes mellitus DOI

Elena V. Misharina,

Alena V. Tiselko, Maria I. Yarmolinskaya

и другие.

Journal of obstetrics and women s diseases, Год журнала: 2025, Номер 73(6), С. 101 - 115

Опубликована: Янв. 30, 2025

Background: Type 1 diabetes mellitus and endometriosis significantly reduce the quality of patient’s life hinder implementation reproductive plans. Studying features clinical course in patients with type will help development new effective safe therapeutic strategies diagnostic methods. Aim: The aim this study was to analyze diseases, hormonal status blood vitamin D (25-hydroxycalciferol) levels combined endometriosis. Materials methods: This prospective included 339 women, whom 79 were (mean age 31.7 ± 5.0 years), 51 31.4 3.7 209 30.2 4.9 years). control group consisted 31 healthy women age. immunochemiluminescent method used determine serum anti-Müllerian hormone, follicle-stimulating luteinizing prolactin, estradiol (days 2–5 menstrual cycle), progesterone 20–23 cycle) during three consecutive cycles, level glycated hemoglobin also studied mellitus. diagnosis all confirmed based on laparoscopic surgery verification by histological examination. Results: When assessing gonadotropins, hormone endometriosis, a decrease noted comparison other groups. gonadotropins prolactin groups comparable. In groups, days cycle lower than group. concentration patients’ peripheral compared group, minimum value 16.3 4.1 ng/ml found those disease no differences between onset its duration, total daily insulin dose, dose per kilogram weight. higher distributing grades prevalence, it that III IV more common without incidence deep infiltrating only, as number reoperations. Conclusions: asymptomatic preclinical period may lead untimely erroneous delayed treatment disease. puberty suffering from risk vascular complications increases ovarian reserve decreases, which requires goals early possible. choosing therapy for mellitus, presence should be taken into account.

Язык: Английский

Процитировано

0